The expression of lipid metabolism genes was upregulated in the Glrx KO livers, whereas adenoviral Glrx replenishment restored SirT1 activity, suppressed lipid metabolism genes and liver steatosis [17]. The gene discussed is GLRX; the disease is Hepatic steatosis.